LABCORP HOLDINGS INC. — Director's Dealing 2016

Mar 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2016-03-11

Reporting Person: Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-11	Common Stock	M	2956	—	Acquired	26410	Direct
2016-03-11	Common Stock	F	1413	$115.49	Disposed	24997	Direct
2016-03-14	Common Stock	S	1543	$115.32	Disposed	23454	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-11	Restricted Stock Unit	$	M	2956	Disposed		Common Stock (2956)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F4: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/2016.

F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.